The Evolution of Resmed Air Solutions: AI-Driven Sleep Apnea Therapy for 2026

Resmed's Air Solutions ecosystem pairs the AirSense 11 with the myAir app, the FDA-cleared Smart Comfort AI feature, the Dawn virtual assistant, and AirView, Resmed's provider-facing remote monitoring platform. Together, they're built around one goal: keeping people on CPAP therapy consistently, since therapy only works if it's used.

The AirSense 11 builds on the AirSense 10 with a smaller footprint, touchscreen interface, and "Test Drive" mode that lets new users get used to air pressure before their first night of real therapy. Its newest feature, Smart Comfort, received FDA clearance in December 2025 as the first AI-enabled medical device of its kind. It draws on more than 100 million nights of de-identified sleep data, along with a user's age, gender, and AHI, to recommend individualized comfort settings, including how gradually pressure ramps up and how much it eases on exhale.¹ It's rolling out in limited beta for new AirSense 11 and myAir users starting in early 2026, with a broader U.S. rollout later in the year.

The myAir app tracks nightly therapy data and provides coaching to help users stay consistent. Dawn, Resmed's generative AI assistant built into myAir, offers 24/7 support for troubleshooting, mask fit questions, and general therapy guidance.² The app also syncs with Apple Health, Health Connect, and smartwatches like the Apple Watch and Samsung Galaxy Watch, pulling in sleep stages, heart rate, and activity alongside therapy data.

A 2017 PwC study of over 128,000 U.S. CPAP users found that patients using both myAir and AirView had an 87% therapy compliance rate, compared to 70% for those using AirView alone, and myAir users averaged 46 minutes more device use per night.³ CPAP only works if it's used consistently, and this kind of coaching and remote support is built specifically to close that gap.

Ready to upgrade your sleep? Explore the latest Resmed AirSense 11 and Air Solutions accessories at The CPAP Shop.

AirView is the cloud platform your provider and The CPAP Shop's team use to monitor therapy remotely. It allows for adjusting pressure settings without an office visit, and flagging a rising AHI or high leak rate early enough to correct it before it affects therapy effectiveness.

Disclaimer: This article describes manufacturer-published features and third-party research on Resmed products; individual results vary, and some features (like Smart Comfort) are in staged rollout and may not yet be available to all users. This isn't medical advice, talk to your doctor or sleep specialist about what's right for your therapy.

Frequently Asked Questions

Is Smart Comfort available now?

It's rolling out in limited beta for new AirSense 11 and myAir users starting in early 2026, with broader availability later in the year.

Do I need a smartwatch to use myAir?

No. Wearable and smartwatch syncing is optional; myAir's core coaching and Dawn assistant work without it.

References

1. "Resmed Receives FDA Clearance for Personalized Therapy Comfort Settings, to be Marketed as Smart Comfort." Resmed Newsroom, December 2025. newsroom.Resmed.com

2. "About Dawn." Resmed. Resmed.com

3. "Resmed's myAir Significantly Improves Adherence to CPAP Therapy in Patients with Sleep Apnea." PwC study, 2017. sleepreviewmag.com

This post was updated with the latest information on September 24, 2026.